Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Ailitong New Material is a Chinese fine-chemicals manufacturer focused on preservatives, humectants, greases, sunscreening agents, and related specialty ingredients used in personal care, cosmetics, food additives, coatings, and some medicine-related applications. Public business-directory and ingredient marketplace sources describe the company as an active manufacturer and exporter based in Qingzhou, Shandong, with products including allantoin, imidazolidinyl urea, diazolidinyl urea, L-citrulline, alpha-ketoglutaric acid, and L-carnitine. The company appears to operate primarily as an industrial and specialty-ingredients supplier rather than a drug developer or biotech company. It has also been described as having in-house R&D capabilities and cooperation with Qingdao University of Technology on new product development. Overall, the business is best characterized as a commercial-stage specialty materials and additives company with some overlap into food and medicine ingredient supply, not a therapeutic healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Ailitong New Materials.